Atrial-specific drug AVE0118 is free of torsades de pointes in anesthetized dogs with chronic complete atrioventricular block
- 30 November 2006
- journal article
- Published by Elsevier BV in Heart Rhythm
- Vol. 3 (11), 1339-1345
- https://doi.org/10.1016/j.hrthm.2006.07.017
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Drug therapy for atrial fibrillation: where do we go from here?Nature Reviews Drug Discovery, 2005
- Diverse phenotypes of outward currents in cells that have survived in the 5-day-infarcted heartAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Atrial‐Specific Drugs:Journal of Cardiovascular Electrophysiology, 2004
- Role of I Kur in Controlling Action Potential Shape and Contractility in the Human AtriumCirculation, 2004
- Effects of the atrial antiarrhythmic drug AVE0118 on cardiac ion channelsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 2004
- New ideas about atrial fibrillation 50 years onNature, 2002
- Distribution of the Muscarinic K+ Channel Proteins Kir3.1 and Kir3.4 in the Ventricle, Atrium, and Sinoatrial Node of HeartJournal of Histochemistry & Cytochemistry, 2001
- Atrial Fibrillation and StrokeStroke, 2001
- Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implicationsArchives of Internal Medicine, 1995
- Sustained depolarization-induced outward current in human atrial myocytes. Evidence for a novel delayed rectifier K+ current similar to Kv1.5 cloned channel currents.Circulation Research, 1993